HDL and apolipoprotein A1 concentrations as markers of cholesterol efflux in middle-aged women: Interaction with smoking

Neuroendocrinology Letters

Volumn 33, Issue SUPPL. 2, 2012, Pages 38-42

  Kralova Lesna, Ivana ^a   Poledne, Rudolf ^a   Pagacova, Libuse ^a   Stavek, Petr ^a   Pitha, Jan ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cholesterol efflux; Lipoproteins; Macrophages; Reverse cholesterol transport; Smoking

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; CHOLESTEROL EFFLUX; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; MACROPHAGE; MIDDLE AGED; PROSPECTIVE STUDY; SMOKING CESSATION; SMOKING HABIT;

EID: 84871062372     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Arnson Y, Shoenfeld Y, Amital H (2010). Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 34: J258-J265.
2. Berrougui H, Cloutier M, Isabelle M, Khalil A (2006). Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Atherosclerosis. 184: 389-396. (Pubitemid 43049725)
3. Cacciola RR, Guarino F, Polosa R (2007). Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem. 14: 1887-1892. (Pubitemid 47163406)
4. Chelland Campbell S, Moffatt RJ, Stamford BA (2008). Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 201: 225-235.
5. Craig WY, Palomaki GE, Haddow JE (1989). Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 25: 784-788. (Pubitemid 19084522)
6. Farbstein D, Levy AP (2012). HDL dysfunction in diabetes: causes and possible treatments. Expert Rev Cardiovasc Ther. 10: 353-361.
7. Garrison RJ, Kannel WB, Feinleib M, Castelli WP, McNamara PM, Padgett SJ (1978). Cigarette smoking and HDL cholesterol: the Framingham offspring study. Atherosclerosis. 30: 17-25. (Pubitemid 8341515)
8. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al. (1989). High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8-15. (Pubitemid 19043669)
9. Hoang A, Murphy AJ, Coughlan MT, Thomas MC, Forbes JM, O'Brien R et al. (2007). Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia. 50: 1770-1779. (Pubitemid 47036662)
10. Huxley RR, Woodward M (2011). Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 378: 1297-1305.
11. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF et al. (2011). Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 13: 127-135.
12. Kralova Lesna I, Suchanek P, Kovar J, Poledne R (2008). Replacement of dietary saturated fatty acids by polyunsaturated fatty acids in diet and reverse cholesterol transport. J Lipid Res. 49: 2414-2418.
13. Kralova Lesna I, Suchanek P, Stavek P, Poledne R (2009). Life style change and reverse cholesterol transport in obese women. Physiol Res. 58, suppl. 1: S47-S52.
14. Lejskova M, Alusík S, Suchanek M, Zecova S, Pitha J (2011). Menopause: clustering of metabolic syndrome components and population changes in insulin resistance. Climacteric. 14: 83-91.
15. de la Llera Moya M, McGillicuddy FC, Hinkle CC, Byrne M, Joshi MR, Nguyen V et al. (2012). Inflammation modulates human HDL composition and function in vivo. Atherosclerosis. 222: 390-394.
16. Mayhan WG, Sharpe GM (1996). Effect of cigarette smoke extract on arteriolar dilatation in vivo. J Appl Physiol. 81: 1996-2003. (Pubitemid 26384525)
17. Miller NE, Thelle DS, Forde OH, Mjos OD (1977). The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1: 965-968.
18. Richard F, Marécaux N, Dallongeville J, Devienne M, Tiem N, Fruchart JC et al. (1997). Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels. Metabolism. 46: 711-715. (Pubitemid 27247309)
19. Tan HC, Tai ES, Sviridov D, Nestel PJ, Ng C, Chan E et al. (2011). Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus. J Clin Lipidol. 5: 467-477.
20. Ueyama K, Yokode M, Arai H, Nagano Y, Li ZX, Cho M et al. (1998). Cholesterol efflux effect of high density lipoprotein is impaired by whole cigarette smoke extracts through lipid peroxidation. Free Radic Biol Med. 24: 182-190. (Pubitemid 28006451)
21. Uehara Y, Miura S, von Eckardstein A, Abe S, Fujii A, Matsuo Y, et al. (2007). Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis. 191: 11-21. (Pubitemid 46227424)